Daniela Kandioler Univ.Prof. Dr. Daniela Kandioler, MBA

Response Prediction, PR-Medienreferentin

Medical University of Vienna –
General Hospital Department of Surgery
Waehringer Guertel 18-20
A-1090 Vienna, Austria

Phone: +43 1 40400 5621
Fax: +43 1 40400 5447

E-mail: Daniela.Kandioler@meduniwien.ac.at
Internet: www.p53.at , www.kandioler.at


CURRICULUM VITAE

Personal data: Date of birth: August 1st, 1967
Place of birth: Vienna, Austria
Ordination: Saarplatz 3, A-1190 Vienna
Phone: +43 1 32 89 554
Employed as: Professor for General Surgery
additionally specialized for Thoracic and Vascular Surgery
Department of Surgery, Medical University of Vienna – General Hospital
Education:

11.6.1985 High school diploma

1987-92 Collaborator at the Ludwig Boltzmann Institute (LBI) for Haematology and Leukemia Research, Hanusch Hospital, Vienna

1991-92 Doctoral thesis on “Posttransplant Lymphoproliferative Diseases” at the Department of Thoracic and Cardiovascular Surgery, University of Vienna

6. 7.1992 Graduation in Medicine at the University of Vienna – Medical School

Vocational Education:

1994-99 Residency in General Surgery at the University of Vienna

1999-00 Residency in General Surgery, Central Hospital of the Capital City of Lower Austria

30.04.2000 Degree of specialization in General Surgery

01.10.2002 Postdoctoral lecture qualification, Professor for General Surgery

30.04.2004 Degree of specialization in Vascular Surgery

01.12.2006 Master of Business Administration (MBA), Health Management Danube University of Krems

01.07.2008 Degree of specialization in Thoracic Surgery

Post Graduate Training:

1992-94 Residency in Molecular Biology, Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna

1992 Fellow, Royal Marsden Hospital, Imperial College, London, Molecular biology for clinical oncology

1992 Video-assisted Thoracic Surgery course, Cincinnati, Ohio

1992 Experimental Video-assisted Thoracic Surgery, Norwalk, Connecticut

1993 Fellow, University of Berlin, Steglitz

1993 IPOKRaTES – Seminar on Molecular Genetics: Academy of Science, Krems

Organisation of International Meetings:

1996 Secretary
2nd Joint Meeting Societies of Thoracic and Cardiovascular Surgery Germany, Austria and Switzerland

2009 President
Annual Meeting ACO/ASSO: Individualized Cancer Therapy

Awards:

1999 Theodor Billroth Prize; Austrian Surgical Society;

1999 VFWF Prize; Association for the Promotion of Scientific Research Medical University of Vienna(1999)

Academic Clinical Trials:

- p53 adjusted neoadjuvant chemotherapy for potentially respectable oesophageal cancer • Pancho (EK NR 128/2007, NCT 00525200), prospective randomized, predicitive marker trial; status : recruiting ; Chair and sponsor representative

- Evaluation of Response to Induction Chemotherapie with Gemcytabine/ Cisplatinum in correlation to p53 genotype, NSCLC Stage IIIA and B, Phase II Study (EK Nr. 140/2004), status: finished ; Sponsor

Board Member:
  • Austrian Society of Surgical Oncology (ACO-ASSO)
  • European Federation of Colorectal Cancer (EFR)
  • TP53 International Collaborative Group
Editor in Chief: Interdisziplinäre Onkologie
Editorial Board Member: MEMO Magazine of European medical oncology
Reviewer:
  • British Journal of Cancer
  • Clinical Chemistry
  • Transplant International
  • European surgery
  • Bio Med Central
  • European J Surg Oncol
Membership (alphabetical order):
  • ÖGC – Austrian Society of Surgery
  • ABCSG – Austrian Breast and Colorectal Cancer Study Group
  • ASCO – American Society of Clinical Oncology
  • ESSO – European Society for Surgical Oncology
  • SIS NETWORK Societe International de Senologie
Membership:

Austrian Society of Surgery

ACO-ASSO Austrian Society of Surgical Oncology

ABCSG – Austrian Breast and Colorectal Cancer Study Group

ASCO – American Society of Clinical Oncology

EFR – European Federation of Colorectal Cancer (Board Member)

Sponsored Doctoral Theses:
  • Mag. Carmen Ludwig: P53 status and response to neoadjuvant therapy in breast cancer
  • Dipl.Ing Sonja Kappel : Genetic tumor profiling using the p53 tumor suppressor gene as diagnostic and predictive marker
Academic research:

Research program is focused on the prediction of response to cancer treatment and translation of knowledge into surgical practice.

1993 -1994
Planning and equipping of the molecular genetic laboratory unit at the Surgical Research Laboratories of the Medical University of Vienna (MUW)

1994- ongoing
Head of the p53 research program (www.p53.at) Medical University of Vienna (MUW) Overall Impact Factor : 217 Overall Research Funding : € 1.132.000 Patents: 2 (applied)